Skip to main content
About
Awards
Events
Value Assessment
News
Donate
Blog
Apply
Improving public health by proactively investing in innovative research, education and value-driven health care
Home
>
Research
>
Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China
Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China